IMO, "consumers" in the sense of the common older people on the street would like to use a relatively cheap and easy to use cancer preventive test that works similar to cholesterol monitoring test. But it is hard and time consuming to retail to individual people on the street. OEM selling to "whole sellers" like Abbott is "easier" for a tiny company, but the Abbott are not good at pioneering new products that has limited dollar volume potential. It is probably also related to selling ability. It is not usually enough just to license the technology out to a big outfit and hope that the big outfit will develop the market. It is important to "manage" and to direct the "relationship" by selling the ultimate customer base, which are the doctors that are suppose to order the tests for their patients, and which are the insurance companies that are going to pay for the tests. These customer base are usually set in their old ways, and they have to be sold to make changes. The past is water under the bridge. The future will be largely depend on the ability and on the effort put in selling, IMO. Getting money out of customers these days can be like pulling teeth. But, IMO, common older people will go for easy to use and low cost cancer preventive testing, although a lot of educational and selling effort will be required for direct selling to this customer base. BOCX people just have to get out there and sell, instead of waiting of the existing medical establishment like the doctors, the insurance companies and the testing labs to do something. BOCX needs to review its business plan in view of the past experiences with the medical establishment.
